Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ARCA Biopharma Inc ABIO

Healthcare Biotechnology
ARCA biopharma, Inc. is a clinical-stage biopharmaceutical company engaged in developing genetically and other targeted therapies for cardiovascular diseases through a precision medicine approach to drug development. The Company's lead product candidate is Gencaro (bucindolol hydrochloride) for the treatment of atrial fibrillation (AF) in patients with chronic heart failure (HF). Gencaro is... see more

Recent & Breaking News (NDAQ:ABIO)

ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire 21 hours ago

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ANSS, HRT, CHX, ABIO

PR Newswire April 10, 2024

SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of ARCA Biopharma, Inc. - ABIO

PR Newswire April 9, 2024

Abio Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Arca Biopharma, Inc. Is Fair to Shareholders

Accesswire April 5, 2024

ARCA BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of ARCA biopharma, Inc. - ABIO

Business Wire April 5, 2024

Kuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to Contact Law Firm

PR Newswire April 5, 2024

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating ARCA biopharma, Inc. Merger

Newsfile April 4, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PIK, CHX, KTRA, ABIO

PR Newswire April 4, 2024

Shareholder Alert: Ademi LLP investigates whether ARCA biopharma, Inc. has obtained a Fair Price in its transaction with Oruka

PR Newswire April 3, 2024

ABIO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of ARCA Biopharma, Inc. Is Fair to Shareholders

Business Wire April 3, 2024

ARCA biopharma and Oruka Therapeutics Announce Merger Agreement

GlobeNewswire April 3, 2024

ARCA biopharma Announces 2023 Financial Results

GlobeNewswire February 1, 2024

ARCA biopharma Announces Third Quarter 2023 Financial Results

GlobeNewswire October 18, 2023

ARCA biopharma Announces Second Quarter 2023 Financial Results

GlobeNewswire July 21, 2023

ARCA biopharma Announces First Quarter 2023 Financial Results

GlobeNewswire April 24, 2023

ARCA biopharma Announces 2022 Financial Results and Provides Corporate Update

GlobeNewswire February 24, 2023

James Flynn Joins ARCA biopharma Board of Directors

GlobeNewswire December 19, 2022

ARCA biopharma Announces Third Quarter 2022 Financial Results

GlobeNewswire October 28, 2022

ARCA biopharma Announces Second Quarter 2022 Financial Results

GlobeNewswire August 2, 2022

Jacob Ma-Weaver Joins ARCA biopharma Board of Directors

GlobeNewswire June 21, 2022